Maternal Child Health in South Africa

By Crystal Lubbe

March 13, 2025

How does economic growth truly impact maternal and child health in Africa?  This article reviews the impact of economic growth and recessions on maternal child health in Africa. It highlights that economic growth can improve health outcomes, such as reducing child mortality and undernutrition. However, its effects are inconsistent across studies. Socio-economic factors like female education, equitable resource distribution, and effective governance are crucial for enhancing these benefits.

Key Insights

  • Economic Growth Impact: Economic growth is linked to better child health outcomes in some studies. However, the relationship is inconsistent and influenced by socio-economic factors.
  • Socio-Economic Factors: Female education, equitable resource distribution, and effective governance are critical for enhancing maternal child health.
  • Inconsistent Findings: Number of studies show insignificant or mixed associations between economic growth and maternal child health outcomes. This highlights the need for comprehensive policies.

Background Context

Economic growth is often seen as a key driver for improving health outcomes. However, its impact on maternal child health in Africa is complex. The region faces high rates of maternal and child mortality. Economic growth does not always lead to better health outcomes due to factors like income inequality and governance issues. The World Health Organization and other global health initiatives stress the importance of addressing socio-economic determinants to achieve health goals. For more insight, access further information here.

Implications

The implications of this study are significant for health economics and outcomes research:

  • Policy Development: Policymakers should consider socio-economic factors when designing health policies to maximise the benefits of economic growth.
  • Alternative Economic Indicators: Indicators like the Inequality-Adjusted Human Development Index (IHDI) and Genuine Progress Indicator (GPI) could provide a more nuanced understanding of economic growth’s impact.
  • Future Research: Further studies should explore the effects of economic growth on non-communicable diseases and surgical capacities in sub-Saharan Africa to address emerging health challenges.
Reference url

Recent Posts

capivasertib cost-effectiveness
      

Capivasertib Cost-Effectiveness in Advanced Breast Cancer

💡What’s the strategy to bring capivasertib’s price within reach of breast cancer patients?

A recent study evaluates capivasertib, an AKT inhibitor, as a second-line treatment for advanced breast cancer, revealing that its costs significantly outweigh the added health benefits. The analysis indicates that to be cost-effective, a substantial reduction in its price is necessary.

Delve into the economic implications of this treatment and the pressing need for pricing reforms in healthcare.

#SyenzaNews #HealthEconomics #costeffectiveness #oncology

reserve antibiotics benefits
           

Reserve Antibiotics Benefits: G-BA Designates Meropenem/Vaborbactam as Critical Reserve Treatment

🔍 What makes reserve antibiotics crucial in the fight against antimicrobial resistance?

The recent assessment of Meropenem/Vaborbactam by the G-BA highlights its vital role as a reserve antibiotic for severe gram-negative infections, ensuring effective treatment options when others fail. With tight regulations and stewardship in place, its designation underscores the importance of preserving these powerful tools in modern medicine.

Dive into the article to explore the implications for healthcare, economics, and patient safety.

#SyenzaNews #HealthcareInnovation #HealthEconomics

robotic surgery approval
               

NICE Grants Conditional Robotic Surgery Approval to Enhance Patient Care and Address Health Inequities

🤖 Are you ready for the future of surgery?

The recent approval of 11 robotic surgery systems by NICE could improve patient care in the NHS, leading to faster recoveries and minimal invasiveness. With a focus on real-world evidence, this transformative step aims to improve health outcomes while addressing access and equity concerns.

Explore how this innovative approach will shape the landscape of surgical procedures in the coming years!

#SyenzaNews #HealthcareInnovation #MedicalDevices #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.